Success Stories
New Possibilities for Delivering Health

UCSF is the birthplace of biotech, nurturing innovators that have gone on to start Genentech, Chiron (now Novartis), and other industry giants. The University continues to nurture a bold spirit of entrepreneurship that enables our researchers and clinicians to pursue new possibilities for delivering health.

Helping Children with ADHD

Industry Licensing
ENDEAVOR technology is available for use at no cost during the acute phase of pandemic.

Data Science in Healthcare

Collaboration
Johnson & Johnson Innovation's Fellowship Program to Recruit Data Scientists

CRISPR Research Lab

Partnership
'Laboratory for Genomic Research:' CRISPR Pioneers with Industry Expertise to Unravel Human Genome

Catalyst + Plus

Project
Catalyst + Plus Provides Additional Support to Previous Catalyst Projects

New Programs

Partnership
UC Drug Discovery Consortium to Speed Development of Life-Saving Therapies 

CTI

Partnership
UCSF and Pfizer’s Center for Therapeutic Innovation (CTI) – the model for industry-university partnerships.

UCSF, GE Healthcare

Partnership
UCSF, GE Healthcare Launch Deep Learning Partnership to Advance Care Globally

Tidepool

Collaboration
Entrepreneurship Center Alumnus Howard Look in collaboration with UCSF faculty

Immunoprofiler Initiative

Project
The UCSF Immuno-profiler Initiative is backed by >$10M from three global pharmaceutical companies

Next-Gen Precision Diagnostics

Project
Charles Chiu Uses Next-Gen Precision Diagnostics to ID Infectious Diseases

Stem-Cell Therapy Grant

Project
Tippie MacKenzie Receives Grant to Use Stem-Cell Therapy to Treat Alpha-Thalassemia Major

PREPARE Website

Project
​Rebecca Sudore Receives $650,000 Grant for PREPARE Website

Zebrafish-to-Patient Approach

Project
Zebrafish-to-Patient Approach Speeds Search for Childhood Epilepsy Treatments

CFTR Activators and Inhibitors

Industry Licensing
Vanda and UCSF Announce License Agreement for CFTR Activators and Inhibitors

ShangPharma Innovation

Collaboration
Advancing the translation of early stage research with ShangPharma

Relievant Medsystems, Inc.

Startup
Relievant Medsystems, Inc., a UCSF Startup, Secured $36 Million in Equity Financing for INTRACEPT®